[Thromboembolic complications after aortic valve prosthesis]. 1977

A S Sharykin

The presented analysis covers the results of aortic valve replacement in 155 patients followed-up for 1 to 11 years after surgery. Actuarial statistics permitted to reveal the dynamics of survival and of good results of different institutions. No anticoagulation whatsoever was given to 85 patients, while 70 others received Phenylin, 30-60 mg/day. Thromboembolism was found to be the leading complication affecting the survival rate and the stability of good results in the late postoperative period. Among the patients receiving no anticoagulants the incidence of thromboembolism proved significantly higher than among those treated with Phenylin.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010630 Phenindione An indandione that has been used as an anticoagulant. Phenindione has actions similar to WARFARIN, but it is now rarely employed because of its higher incidence of severe adverse effects. (From Martindale, The Extra Pharmacopoeia, 30th ed, p234) 2-Phenyl-1,3-indandione,Dindevan,Fenilin,Phenylindanedione,Phenyline,Pindione,2 Phenyl 1,3 indandione
D011182 Postoperative Care The period of care beginning when the patient is removed from surgery and aimed at meeting the patient's psychological and physical needs directly after surgery. (From Dictionary of Health Services Management, 2d ed) Care, Postoperative,Postoperative Procedures,Procedures, Postoperative,Postoperative Procedure,Procedure, Postoperative
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006350 Heart Valve Prosthesis A device that substitutes for a heart valve. It may be composed of biological material (BIOPROSTHESIS) and/or synthetic material. Prosthesis, Heart Valve,Cardiac Valve Prosthesis,Cardiac Valve Prostheses,Heart Valve Prostheses,Prostheses, Cardiac Valve,Prostheses, Heart Valve,Prosthesis, Cardiac Valve,Valve Prostheses, Cardiac,Valve Prostheses, Heart,Valve Prosthesis, Cardiac,Valve Prosthesis, Heart
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths

Related Publications

A S Sharykin
September 1968, Archives des maladies du coeur et des vaisseaux,
A S Sharykin
October 1968, Munchener medizinische Wochenschrift (1950),
A S Sharykin
June 1983, Annales de cardiologie et d'angeiologie,
A S Sharykin
July 1973, The Journal of the Kansas Medical Society,
A S Sharykin
January 1969, Grudnaia khirurgiia (Moscow, Russia),
A S Sharykin
February 1978, American heart journal,
A S Sharykin
March 1971, Wiener klinische Wochenschrift,
A S Sharykin
January 1971, Grudnaia khirurgiia (Moscow, Russia),
Copied contents to your clipboard!